Loading...
Loading...
By Sofía Garduño - Fri, 01/16/2026 - 10:14
Novo Nordisk launches Wegovy pill in the United States, introducing the first oral GLP-1 option for weight management.
Featured content
Partnership Content
https://mexicobusiness.news/tag/orforglipron
More Health
By Sofía Garduño - Fri, 11/21/2025 - 12:32
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By Sofía Garduño - Fri, 11/21/2025 - 11:55
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By MBN Staff - Mon, 11/10/2025 - 11:12
Lilly partners with the US government to expand access to obesity drugs, reinforcing its long-term commitment to healthcare affordability.
By MBN Staff - Thu, 09/18/2025 - 09:13
Orforglipron lowered A1C and body weight more than oral semaglutide in a 52-week Phase 3 trial for type 2 diabetes, reports Eli Lilly.
By MBN Staff - Sat, 06/28/2025 - 09:32
New trial data shows promising results for two GLP-1 treatments for obesity and type 2 diabetes, with studies conducted in Mexico and other countries.
By MBN Staff - Fri, 04/25/2025 - 15:26
Lilly’s oral GLP-1 drug orforglipron met key goals in a Phase 3 trial, showing significant A1C and weight reductions in type 2 diabetes patients.
